These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23315386)

  • 41. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
    Yamada Y; Potters L; Zaider M; Cohen G; Venkatraman E; Zelefsky MJ
    Am J Clin Oncol; 2003 Oct; 26(5):e130-5. PubMed ID: 14528087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
    Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer.
    Kollmeier MA; Pei X; Algur E; Yamada Y; Cox BW; Cohen GN; Zaider M; Zelefsky MJ
    Brachytherapy; 2012; 11(4):271-6. PubMed ID: 22192495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose-rate brachytherapy for prostate cancer: preplanning vs. intraoperative planning-preplanning is best.
    Blasko JC
    Brachytherapy; 2006; 5(3):139-42; discussion 145. PubMed ID: 16864061
    [No Abstract]   [Full Text] [Related]  

  • 46. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
    Hinnen KA; Monninkhof EM; Battermann JJ; van Roermund JG; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):883-8. PubMed ID: 21300477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for
    Peters M; Smit Duijzentkunst DA; Westendorp H; van de Pol SMG; Kattevilder R; Schellekens A; van der Voort van Zyp JRN; Moerland MA; van Vulpen M; Hoekstra CJ
    Brachytherapy; 2017; 16(2):282-290. PubMed ID: 28110899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Placement of empty catheters for an HDR-emulating LDR prostate brachytherapy technique: comparison to standard intraoperative planning.
    Niedermayr TR; Nguyen PL; Murciano-Goroff YR; Kovtun KA; Neubauer Sugar E; Cail DW; O'Farrell DA; Hansen JL; Cormack RA; Buzurovic I; Wolfsberger LT; O'Leary MP; Steele GS; Devlin PM; Orio PF
    Brachytherapy; 2014; 13(4):375-9. PubMed ID: 24613569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between preoperative and real-time intraoperative planning ¹²⁵I permanent prostate brachytherapy: long-term clinical biochemical outcome.
    Matzkin H; Chen J; German L; Mabjeesh NJ
    Radiat Oncol; 2013 Dec; 8():288. PubMed ID: 24341548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [High-dose brachytherapy for prostate cancer in real time using 192-IR (specifics of dosimetric planning)].
    Novikov SN; Kanaev SV; Novikov RV; Iliin ND; Gotovchikova MY
    Vopr Onkol; 2015; 61(1):130-6. PubMed ID: 26016159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of dose-volume histograms after prostate seed implantation. 4-year experience.
    Hoinkis C; Hakenberg OW; Lehmann D; Winkler C; Wirth MP; Herrmann T
    Strahlenther Onkol; 2004 Sep; 180(9):550-6. PubMed ID: 15378185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients.
    Westendorp H; Hoekstra CJ; Immerzeel JJ; van de Pol SM; Niël CG; Kattevilder RA; Nuver TT; Minken AW; Moerland MA
    Med Phys; 2017 Apr; 44(4):1257-1267. PubMed ID: 28192614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.
    Kudchadker RJ; Pugh TJ; Swanson DA; Bruno TL; Bolukbasi Y; Frank SJ
    Med Dosim; 2012; 37(4):387-90. PubMed ID: 22560295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society.
    Nag S; Ciezki JP; Cormack R; Doggett S; DeWyngaert K; Edmundson GK; Stock RG; Stone NN; Yu Y; Zelefsky MJ;
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1422-30. PubMed ID: 11728703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implant.
    Vigneault E; Mbodji K; Carignan D; Martin AG; Miksys N; Thomson RM; Aubin S; Varfalvy N; Beaulieu L
    Brachytherapy; 2019; 18(6):787-792. PubMed ID: 31444133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-time optimized intraoperative dosimetry for prostate brachytherapy: a pilot study.
    Beyer DC; Shapiro RH; Puente F
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1583-9. PubMed ID: 11121665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis.
    Shanahan TG; Nanavati PJ; Mueller PW; Maxey RB
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):490-6. PubMed ID: 12023154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experience of brachytherapy using I-125 seed permanent implants for localized prostate cancer].
    Toya K; Yorozu A; Ohashi T; Okada M; Itoh R; Monma T; Saito S; Fukada J; Sugawara A; Dokiya T
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):432-7. PubMed ID: 16334398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy.
    Lee WR; deGuzman AF; Tomlinson SK; McCullough DL
    Radiother Oncol; 2002 Nov; 65(2):123-7. PubMed ID: 12443808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.